Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis

International Urology and Nephrology

Volumn 44, Issue 5, 2012, Pages 1451-1459

  Sofroniadou, Sofia ^a   Kassimatis, Theodoros ^a   Srirajaskanthan, Rajaventhan ^a   Reidy, John ^a   Goldsmith, David ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Angiotensin I converting enzyme inhibitors; Angiotensin receptor blockers; Hypertension; Renal artery stenosis

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EDETIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANGINA PECTORIS; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATHEROSCLEROTIC KIDNEY ARTERY STENOSIS; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEATH; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; MALE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PROSPECTIVE STUDY; RENAL SURVIVAL; SURVIVAL; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL ARTERY OBSTRUCTION; RENIN-ANGIOTENSIN SYSTEM; TIME FACTORS;

EID: 84867888212     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-0091-y     Document Type: Article

References (21)

1. Derkx FH, Schalekamp MA (1994) Renal artery stenosis and hypertension. Lancet 344:237-239
2. Ram CV (1997) Renovascular hypertension. Curr Opin Nephrol Hypertens 6:575-579
3. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG et al (2002) Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 36:443-451
4. Olin JW, Melia M, Young JR, Graor RA, Risius B (1990) Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 88:46N-51N
5. Valentine RJ, Clagett GP, Miller GL, Myers SI, Martin JD, Chervu A (1993) The coronary risk of unsuspected renal artery stenosis. J Vasc Surg 18:433-440
6. Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen SC et al (2005) Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 68:293-301
7. Conlon PJ, Little MA, Pieper K, Mark DB (2001) Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 60:1490-1497
8. Mui KW, Sleeswijk M, van den Hout H, van Baal J, Navis G, Woittiez AJ (2006) Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J Am Soc Nephrol 17:2069-2074
9. ASTRAL Investigators, Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J (2009) Revascularization versus medical therapy for renal artery stenosis. N Engl J Med 361:1953-1962
10. Iwanaga Y, Kihara Y, Inagaki K, Onozawa Y, Yoneda T, Kataoka K et al (2001) Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure. Circulation 104:606-612
11. Yamazaki T, Shiojima I, Komuro I, Nagai R, Yazaki Y (1994) Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction. J Hypertens Suppl 12:S153-S157
12. The HOPE Study Investigators (1996) The HOPE (Heart Outcomes Prevention Evaluation) study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 12: 127-137
13. Goldsmith DJ, Reidy J, Scoble J (2000) Renal arterial intervention and angiotensin blockade in atherosclerotic nephropathy. Am J Kidney Dis 36:837-843
14. Tullis MJ, Caps MT, Zierler RE, Bergelin RO, Polissar N, Cantwell-Gab K et al (1999) Blood pressure, antihypertensive medication, and atherosclerotic renal artery stenosis. Am J Kidney Dis 33:675-681
15. Franklin SS, Smith RD (1986) A comparison of enalapril plus hydrochlorothiazide with standard triple therapy in renovascular hypertension. Nephron 44(suppl 1):73-82
16. Tillman DM, Malatino LS, Cumming AM, Hodsman GP, Leckie BJ, Lever AF et al (1984) Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function. J Hypertens Suppl 2:S93-S100
17. Hodsman GP, Brown JJ, Cumming AM, Davies DL, East BW, Lever AF et al (1983) Enalapril (MK421) in the treatment of hypertension with renal artery stenosis. J Hypertens 1(suppl):109-117
18. Reams GP, Bauer JH (1985) Enalapril versus triple-drug therapy in the treatment of renovascular hypertension. Drugs 30(suppl 1):59-69
19. Khosla S, Ahmed A, Siddiqui M, Trivedi A, Benatar D, Salem Y (2006) Safety of angiotensin-converting enzyme inhibitors in patients with bilateral renal artery stenosis following successful renal artery stent revascularization. Am J Ther 13:306-308
20. Losito A, Errico R, Santirosi P, Lupattelli T, Scalera GB, Lupattelli L (2005) Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transpl 20:1604-1609
21. Hackam DG, Duong-Hua ML, Mamdani M, Li P, Tobe SW, Spence JD, Garg AX (2008) Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J 156:549-555